Evidence map›Paper›PMID 21647794›Full record

ReviewJournal of cardiovascular translational research2011

Biomaterials advances in patches for congenital heart defect repair.

Seokwon Pok, Jeffrey G Jacot

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of cardiovascular translational research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Reconstruction of the Aortic Arch in Neonates and Infants: The Importance of Patch Material.World journal for pediatric & congenital heart surgery · 2021
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Decellularized Aortic Scaffold Alleviates HBioMed research international · 2020
    Article
  13. Article
  14. Recent Development in Therapeutic Cardiac Patches.Frontiers in cardiovascular medicine · 2020
    Review
  15. Article
  16. Cardiomyocytes Derived from HumanScientific reports · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Lyophilized allografts without pre-treatment with glutaraldehyde are more suitable than cryopreserved allografts for pulmonary artery reconstruction.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2016
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Seokwon PokDepartment of Bioengineering, Rice University, Houston, TX, USA.
Jeffrey G Jacot

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article reviews current applications and novel candidate biomaterials for use as tissue-engineered scaffolds in pediatric cardiac tissue engineering. This overview of different types of biomaterials includes naturally derived and synthetic polymers and their biological, physical, and biomechanical properties for the use as a patch or baffle for surgical reconstruction of congenital heart defects. Applications and characteristics of composite biomaterials are highlighted with their respective feasibilities in use as cardiac scaffolds. Currently, a wide range of biomaterials has been introduced for cardiovascular reconstruction for complex congenital cardiac defects. However, there are still many remaining challenges for engineered tissue implantations.

Indexed as

Biocompatible MaterialsTissue ScaffoldsAnimalsCardiac Surgical ProceduresHeart Defects, CongenitalHumansPolymersTissue EngineeringBiocompatible MaterialsPolymers

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.